Loading clinical trials...
Loading clinical trials...
Moving PD-1 Blockade With Pembrolizumab Into Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer
Conditions
Interventions
3-Dimensional Conformal Radiation Therapy
Carboplatin
+4 more
Locations
3
United States
Yale Cancer Center
New Haven, Connecticut, United States
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
University of Pennsylvania/Abramson Cancer Center
Philadelphia, Pennsylvania, United States
Start Date
August 4, 2016
Primary Completion Date
October 24, 2019
Completion Date
February 29, 2024
Last Updated
December 16, 2025
NCT01629498
NCT02495896
NCT04062708
NCT01993810
NCT03916419
NCT02186847
Lead Sponsor
Rutgers, The State University of New Jersey
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions